Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 6/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.33 |
| ▸ | MEN1 | O00255 | 3/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.33 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.33 |
| ▸ | KDM4A | O75164 | 1/20 | 0.33 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 3/20 | 0.32 |
| ▸ | THRB | P10828 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8297572 | 0.89 | — | — | |
| SCHEMBL30958906 | 0.77 | MAPT (0.45) | MAPTALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL200674 | 0.69 | MAPT (0.41) | MAPTALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL11820394 | 0.67 | MAPT (0.40) | MAPTALDH1A1HSD17B10MEN1KMT2A | |
| Calcium SCHEMBL30891545 | 0.67 | MAPT (0.40) | MAPTALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL8468520 | 0.67 | MAPT (0.40) | MAPTALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL1263023 | 0.67 | MAPT (0.40) | MAPTALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL1263355 | 0.67 | MAPT (0.40) | MAPTALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL22628805 | 0.67 | MAPT (0.40) | MAPTALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL4006398 | 0.67 | MAPT (0.40) | MAPTALDH1A1HSD17B10MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8664289-B2 | Dye and coloring photosensitive composition | ADEKA CORPORATION (JP) | 2014-03-04 | — | — | US | disclosed |
| US-8664289-B2 | Dye and coloring photosensitive composition | ADEKA CORPORATION (JP) | 2014-03-04 | — | — | US | disclosed |
| EP-2620476-A1 | PIGMENT AND COLORED PHOTOSENSITIVE COMPOSITION | Adeka Corporation (JP) | 2013-07-31 | — | — | EP | disclosed |
| US-20130041062-A1 | DYE AND COLORING PHOTOSENSITIVE COMPOSITION | ADEKA CORPORATION (JP) | 2013-02-14 | — | — | US | disclosed |
| US-20130041062-A1 | DYE AND COLORING PHOTOSENSITIVE COMPOSITION | ADEKA CORPORATION (JP) | 2013-02-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130041062-A1 | DYE AND COLORING PHOTOSENSITIVE COMPOSITION | IK, CRY1, ABCG2 | MAPT 458/4885ALDH1A1 155/4885HSD17B10 833/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.